SFC Fluidics’ Post

Starting a business demands a mix of paranoia and passion. You've got to have that relentless drive to navigate through the imperfections. It's crucial to focus on creating value, not just for investors but also ensuring you, as a founder, have the resilience to persist and achieve milestones. Considering all options is key, even those early strategic partnerships or deals you might initially hesitate over. Scott Huennekens experiences with Digirad, Volcano Corporation, and collaborations with giants like GE and Philips, plus non-dilutive funding from companies like Fukuta and Goodman, it's evident that creativity and flexibility are vital. Rarely do perfect financing scenarios unfold; only in about 10-20% of cases will things align ideally. The goal is to remain adaptable without compromising your future value-creation capability. #medtech #medicaldevice #medicaldevices #healthcare

𝐈𝐧𝐒𝐢𝐥𝐢𝐜𝐨𝐓𝐫𝐢𝐚𝐥𝐬 𝐅𝐢𝐧𝐚𝐥𝐢𝐬𝐭 𝐚𝐭 𝐒𝐂𝐎𝐏𝐄 𝟐𝟎𝟐𝟒 𝐈𝐧𝐚𝐮𝐠𝐮𝐫𝐚𝐥 𝐒𝐭𝐚𝐫𝐭-𝐔𝐩 𝐏𝐢𝐭𝐜𝐡   We are excited to announce that 𝐈𝐧𝐒𝐢𝐥𝐢𝐜𝐨𝐓𝐫𝐢𝐚𝐥𝐬 is among the selected #finalists for the Clinical Trial Tech's inaugural Start-Up Pitch Contest, a highlight of the #SCOPEsummit 2024.   We've been chosen - by Cambridge Innovation Institute (CII)- from over 100 innovative companies, based on core #technology and #capabilities including: Value Proposition/Market Potential; Business Model/Scalability; Current Investment/Revenue Strategy; Application of Future Investment.   🗓 On February 12, we will be presenting our cutting-edge #insilico solutions at Rosen Shingle Creek in Orlando, FL., competing for the title of 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹 𝗧𝗲𝗰𝗵’𝘀 𝗦𝘁𝗮𝗿𝘁-𝗨𝗽 𝗼𝗳 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿. 💪 ℹ https://lnkd.in/gqRkZzZs #clinicaltrials #clinicaltrialinvestor #partnering #modelingandsimulation #computationalmodeling

❔ What are the barriers hindering consideration of this burgeoning sector? ❔ How can we attract new and larger investors? These are just a couple of questions that Maria De Santis, Muse Capital, Abbie Strabala, True Wealth Ventures, Rachel Braun Scherl, SPARK Solutions for Growth and Sriya Srinath, Morgan Health will answer in our next panel "Unlocking Potential: Perspectives from Prominent Investors in Femtech and Consumer Health". From understanding market trends to addressing regulatory concerns and fostering innovation, our panellists will offer strategic perspectives on unlocking investment opportunities in Femtech and consumer health. #FCIS #Femtech #Innovation #WomensHealth

Aaron Leibtag cofounded Pentavere Research Group, a digital health company that identifies patients not receiving the medications or interventions they should be receiving because critical data is buried in a patient’s electronic health record. Despite having just 15 employees, they attracted an acquisition offer that valued Pentavere at $15 million. In this episode, you'll discover how to: 👉 Find a strategic acquirer. 👉 Steer an acquirer's focus towards future potential over historical EBITDA. 👉 Avoid re-trading by leveraging radical candor. 👉 Avoid having your proceeds locked in a risky earn-out. 👉 Decipher the disparities between debt and equity in a term sheet. Listen now:

Intractable chronic pain. Three lousy words. The only thing that makes them worse individually is them being used together. No way to go through life. Glad to hear that some companies are focused on doing something about it. Along with investors determined to see their technology comes to patients. Nalu Medical, Inc. raised a considerable round. Their device is tiny, battery free, can barely be seen under the skin, upgradeable and easily reversible if necessary. #neurostimulation receiving needed innovation. Led by Novo Holdings along with Gilde Healthcare MVM Partners Endeavor Decheng Capital Longitude Capital Advent Life Sciences Aperture Venture Partners and Pura Vida. Led by the team of Thomas A. West Allen Meacham Jon Ruais Jeff Swiecki Lee Hartley Bick Sellers Chelsea Gutierrez easy to see where the confidence in the company comes from. Continued success in 2024 #medtech #investment

🚀🔄 Founding a company with a vision is one thing. Transforming the company as times change is another. Dr. Andy Fischer, Group CEO of Medgate, and Fabian Dieziger, Co-founder and Partner of Supertext, discuss the importance of regularly adapting the business model, and explain why human intelligence still makes all the difference, even with the advance of technology. ➡️ In the UBS Growth Talk #13, they share what makes for a successful transformation process based on their many years of experience: https://lnkd.in/e7VKvjPd #UBSGrowthTalk #Transformation

🌐 Elevate Your Brand with ViaRx.com – A Premium Domain! 🚀 Perfect for creating a memorable online presence, this versatile and easy-to-remember domain is ideal for any business looking to stand out. Don't miss out – own a piece of prime digital real estate today! Visit ViaRx.com now and see for yourself! #DomainListing #DomainOpportunity #StartUpDomains #PremiumDomainName

"Commencing on a journey in the lab business is not just a venture;it's a profound opportunity to serve mankind while making sound financial strides. The healthcare industry is evolving, and laboratories play a crucial role in diagnostics and research. Our commitment is twofold: advancing science for the greater good and ensuring a profitable venture. Lab businesses are not only a gateway to scientific discovery but also a lucrative investment. Join us in this meaningful pursuit where service to humanity aligns seamlessly with financial success. Let's explore the boundless potential of both impact and profit in the realm of laboratory services. 💼🔬💰 #LabBusiness #ProfitableVenture #HealthcareInnovatio #Bloodtestconsultancy

🚨 Big News in Life Sciences 🚨 VaLogic Bio, based in Frederick, MD, just acquired Facility Logix LLC, a firm specializing in planning and project management for life sciences facilities! 🏗️ While the financial details weren’t disclosed, this strategic move will allow VaLogic Bio to create a full-service outsourced solutions platform by integrating Facility Logix’s services. Why it matters: • Facility Logix, led by Founder Pat Larrabee, is known for driving growth in science and tech companies through long-term partnerships and innovative facility projects. 🔬 • VaLogic, under CEO Bill Robertson, is a GxP compliance platform offering services like calibration, CQV, and environmental monitoring. ⚙️ This acquisition strengthens VaLogic Bio’s ability to support the rapidly growing life sciences sector with comprehensive, compliance-driven solutions. 💡 The future of life sciences infrastructure is here—are you ready? 🚀 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #Acquisition #LifeSciences #TechInnovation #Compliance #ProjectManagement #Growth #VaLogicBio #FacilityLogix #FutureTechly

Life Science experts Adrian Toutoungi and Nicholas Vollers, review the key considerations from the Bruntwood SciTech event, hosted at our Cambridge office, for TechBio investors, CEOs and founders considering their exit strategy: https://bit.ly/430qo1G   Key takeaways include the importance of defining your product, an analysis of the types of exit opportunities available to TechBio companies, considerations when valuing assets and platforms, and how to approach a pharma collaboration.   #LifeSciences #TechBioExits #TechBioInvestors #PrivateWealth